CTOs on the Move

EyeCare Services Partners

www.espmgmt.com

 
EyeCare Services Partners (ESP) provides ownership and practice management of ophthalmologic, optometric and ambulatory surgery centers nationwide. ESP offers eye care providers and ambulatory surgery center owners compelling and effective solutions for today`s constantly changing healthcare environment. Utilization of our resources and expertise eliminates the stress of practice management. We are creating the nation`s leading eyecare services company in both quality and scale by consolidating ophthalmologic and optometric practices and ambulatory surgery centers that are locally dominant and clinically differentiated. We provide a patient centric model that delivers outstanding care and quality outcomes through our providers and staff by leveraging ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $10-50 Million
  • www.espmgmt.com
  • 2727 North Harwood Street Suite 350
    Dallas, TX USA 75201
  • Phone: 844.377.6468

Executives

Name Title Contact Details
James Lumby
 Chief Information Security Officer Profile

Similar Companies

GTESS Corporation

GTESS Corporation is a Richardson, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Particle Health

Particle Health is on a mission to solve the biggest problem facing the American healthcare system - data sharing.

OncoGenex

OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.

Duos

DUOS is reimagining freedom at any age. As a technology-enabled service provider, DUOS connects people to the essential resources required to attain the highest level of health. Our advanced technology allows us to aggregate historically siloed data and resources from across the ecosystem, breaking down barriers to health literacy and access to care and enabling seamless and timely connections with complete visibility and feedback throughout the process.

Abbiotec

Abbiotec is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.